Three Versus Six Months of Adjuvant Oxaliplatin-Containing Chemotherapy for Patients With Stage III Colorectal Cancer: A Contemporary Real-World Analysis.

Autor: Krishnan T; BC Cancer-Vancouver, University of British Columbia, Vancouver, BC., Leung E; Department of Medicine, University of British Columbia, Vancouver, BC., Solar Vasconcelos JP; BC Cancer-Vancouver, University of British Columbia, Vancouver, BC., Lim H; BC Cancer-Vancouver, University of British Columbia, Vancouver, BC., Loree JM; BC Cancer-Vancouver, University of British Columbia, Vancouver, BC., Davies J; BC Cancer-Vancouver, University of British Columbia, Vancouver, BC., Gill K; BC Cancer-Vancouver, University of British Columbia, Vancouver, BC., Gill S; BC Cancer-Vancouver, University of British Columbia, Vancouver, BC.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Oct 09, pp. OP2400492. Date of Electronic Publication: 2024 Oct 09.

Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials.

Autor: Solar Vasconcelos JP; BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Chen N; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada., Titmuss E; BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., Tu D; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Brule SY; The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada., Goodwin R; The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada., Jonker DJ; The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada., Price T; Queen Elizabeth Hospital, Adelaide, South Australia, Australia., Zalcberg JR; Department of Medical Oncology, Alfred Health and School of Public Health, Faculty of Medicine, Monash University, Melbourne, Victoria, Australia., Moore MJ; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Karapetis CS; Flinders University, Adelaide, South Australia, Australia., Siu L; Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Shapiro J; Department of Medical Oncology, Alfred Health and School of Public Health, Faculty of Medicine, Monash University, Melbourne, Victoria, Australia., Simes J; The University of Sydney, Sydney, New South Wales, Australia., Gill S; BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada., O'Callaghan CJ; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Loree JM; BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Mar 15; Vol. 30 (6), pp. 1121-1130.

Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022.

Autor: Gill S; British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada., Ahmed S; Saskatchewan Cancer Agency, Saskatoon, SK S4W 0G3, Canada., Anderson B; Western Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada., Berry S; Department of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada., Lim H; British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada., Phang T; Department of Surgery, University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Sharma A; Central Alberta Cancer Centre, School of Medicine, University of Calgary Cumming, Red Deer, AB T4N 6R2, Canada., Solar Vasconcelos JP; British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada., Gill K; British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada., Iqbal M; Allan Blair Cancer Centre, Regina, SK S4T 7T1, Canada., Tankel K; Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada., Chan T; British Columbia Cancer Agency, Surrey, BC V3V 1Z2, Canada., Recsky M; Kelowna General Hospital, Kelowna, BC V1Y 1T2, Canada., Nuk J; British Columbia Cancer Hereditary Cancer Program, Victoria, BC V8R 6V5, Canada., Paul J; CancerCare Manitoba, University of Manitoba, Winnipeg, MB R3E 0V9, Canada., Mahmood S; Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada., Mulder K; Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Aug 29; Vol. 30 (9), pp. 7964-7983. Date of Electronic Publication: 2023 Aug 29.